OceansBio Ltd Announces Its Entry Into Device Similar – Starting a New Era in Implantable Electroceuticals
New York, NY, United States, 26th Aug 2025 – OceansBio Ltd., a leading innovator in biomedical technology, today announced its entry into the emerging era of “Device Similar” for implantable electroceuticals. With a focus on neurological disorders such as Parkinson’s disease, epilepsy, depression, and chronic pain, OceansBio is positioning itself at the forefront of this transformative shift in medical device innovation.
OceansBio Ltd.’s Vision for Device Similars
Building on the established concept of biosimilars in the pharmaceutical industry, Device Similars are designed to replicate the function, quality, and safety of original implantable devices once patents expire, at a fraction of the cost. OceansBio Ltd. is developing advanced solutions to ensure greater accessibility for patients...